Misinformation about herpes is everywhere. From school health classes to late-night Google searches, what many people think they know about the virus is often shaped more by fear and stigma than by fact. Common herpes myths—like the idea that it only affects people with many sexual partners, or that you can always tell when someone has it—leave out the reality that herpes is incredibly common, often silent, and not limited to any one type of person.
Unfortunately, public education around herpes hasn’t kept up with science. Media coverage and health messaging often rely on fear-based language that frames the virus as dirty or dangerous. Even the way antiviral medications are marketed tends to focus on hiding symptoms rather than helping people feel informed and empowered. This lack of balanced, accessible information leaves space for shame to grow.
And that shame has consequences. The stigma around herpes can make it difficult for people to talk openly about their diagnosis, even with close partners or healthcare providers. Many people feel isolated or anxious, not because of the virus itself, but because of how others might respond. Some delay getting tested or treated out of fear, increasing the risk of transmission and missing out on support they deserve.
The goal of this post is simple: to challenge some of the most harmful herpes myths with accurate, compassionate information. Because everyone deserves to feel informed—not ashamed—when it comes to their health.
Myth #1: Only “Promiscuous” People Get Herpes
One of the most persistent herpes myths is the idea that only people with multiple sexual partners—or what society unfairly labels as “promiscuous”—contract the virus. In truth, herpes is one of the most common viral infections worldwide, and it doesn’t discriminate based on lifestyle, relationship status, or personal values.
Globally, billions of people live with herpes. HSV-1, the type typically associated with cold sores, affects an estimated 3.7 billion people under age 50. HSV-2, often linked to genital herpes, affects around 417 million people aged 15 to 49. In the U.S., research has shown that over half of women who tested positive for HSV-1 or HSV-2 were unaware they even had the virus. These numbers highlight a simple fact: herpes is widespread and often goes unnoticed.
The reality is that people often acquire HSV-1 in early childhood, long before sexual activity ever begins. It can be passed through casual contact—like kissing or sharing utensils—with caregivers or family members. In some regions, such as Sub-Saharan Africa, a large majority of children have HSV-1 antibodies by age four, and by adulthood, that number climbs even higher.
HSV-2 is typically transmitted through sexual contact, but it’s also commonly passed between partners in long-term, monogamous relationships. Many people don’t know they’re infected because they never develop noticeable symptoms, and this makes unintentional transmission more likely. In fact, most new cases of HSV-2 happen within ongoing relationships—not one-night stands.
Perhaps the most overlooked aspect of herpes is that it doesn’t need visible symptoms to spread. Asymptomatic shedding—when the virus is present on the skin without any sores—can still lead to transmission. Researchers estimate that about 80% of people with herpes don’t know they have it, simply because they’ve never experienced an outbreak or didn’t recognize the signs.
Reducing stigma starts with understanding that herpes is incredibly common and often invisible. It’s not a marker of someone’s choices or character—it’s a virus, like many others, that can affect anyone.
Myth #2: You Can Always Tell If Someone Has Herpes
It’s a common belief that herpes is always visible—that if someone has it, you’ll be able to see a sore or know from a conversation. But one of the most misleading herpes myths is the idea that symptoms are obvious or always present. In reality, most people who have herpes don’t know it.
Studies show that up to 90% of people with HSV-2 are unaware of their status. Symptoms can be so mild that they’re mistaken for something else—like a rash, razor burn, or even a yeast infection—or may not show up at all. Some people only discover they have herpes after routine testing or when a partner experiences symptoms.
Even those who think they’re symptom-free may later recognize subtle signs of the virus once they know what to look for. Tingling, itching, or small patches of irritation can signal a mild outbreak, but these early signs are easy to overlook, especially without a diagnosis. Herpes doesn’t always follow a clear or predictable pattern, which makes awareness and education all the more important.
One of the biggest challenges with herpes is that it can be spread even when no symptoms are present. This is called asymptomatic shedding, and it accounts for the majority of HSV-2 transmissions. The virus can be active on the skin or mucous membranes without any sores, pain, or visible changes. Shedding isn’t constant, but it happens frequently—more often than most people realize. In some studies, HSV-2 was detected in symptom-free individuals on roughly one out of every ten days, and even more often in those with known outbreaks.
While antiviral medications can significantly reduce shedding and lower the risk of passing the virus on, they can’t stop it entirely. Even people who take suppressive therapy daily may shed the virus and not know it. This is why herpes can spread silently and why it’s so important to approach it with facts, not assumptions.
Herpes doesn’t have a “look,” and a person’s appearance—or even their own awareness—isn’t a reliable indicator of their HSV status. Challenging this myth helps remove blame and encourages open, informed conversations about sexual health.
Myth #3: You Can Get Herpes from a Toilet Seat
This is one of the most persistent and anxiety-inducing herpes myths—and thankfully, it’s also one of the easiest to debunk. The short answer? No, you cannot catch herpes from a toilet seat.
Herpes simplex virus (HSV) spreads through direct skin-to-skin contact, typically involving mucous membranes or broken skin. Genital herpes, for example, is transmitted through intimate contact—not from sitting on a public toilet. The virus doesn’t jump from surfaces to skin, and it doesn’t live long enough outside the body to pose any real risk in everyday situations like using a bathroom.
HSV is actually quite fragile. In lab settings under ideal conditions—warm and humid—it may survive on plastic for a few hours, but in real life, those conditions don’t hold. As surfaces dry, which happens quickly on hard objects like toilet seats, the virus becomes inactive, usually within 30 to 60 minutes or even sooner. The likelihood of transmission from a surface would require a perfect storm of events: fresh, infectious virus on the surface and immediate contact with a large amount of it through broken skin or mucosa. That scenario is biologically implausible and not how the virus works.
Despite this, the myth continues—likely fueled by fear and the desire to explain an unexpected diagnosis. But there is no scientific evidence to support the idea that HSV is spread through toilets, towels, or other inanimate objects. Public health experts and infectious disease researchers are in firm agreement: herpes is not something you catch from a bathroom.
Dispelling this myth not only clears up unnecessary fear but also helps people better understand how HSV is actually transmitted. And that understanding is the first step toward reducing stigma and improving prevention.
Myth #4: Cold Sores Aren’t Herpes
Many people think of cold sores as a harmless nuisance—something you get from stress, sun exposure, or a change in the weather. What often gets left out is that cold sores are caused by herpes simplex virus type 1 (HSV-1). Yes, cold sores are herpes.
HSV-1 is the primary cause of oral herpes and is responsible for the familiar blisters that show up around the lips or mouth. In some regions, more than 70% of the population carries HSV-1, often acquiring it in childhood through casual contact like kissing or sharing utensils. Despite its prevalence, the term “cold sore” is frequently used as a way to avoid the word “herpes,” likely because of the stigma that surrounds the diagnosis. But medically speaking, they’re one and the same.
What’s less widely known is that HSV-1 can also cause genital herpes. Through oral-genital contact, HSV-1 is now a leading cause of genital herpes in many countries—especially among young adults. While HSV-2 is still more commonly linked to genital infections, HSV-1 has become a significant contributor to new cases.
Genital HSV-1 tends to recur less often than HSV-2 and is associated with lower levels of asymptomatic shedding. However, it still establishes a lifelong presence in the body and can be passed on even when symptoms aren’t visible. So while the patterns may differ between types, both can be transmitted, and both deserve to be taken seriously.
HSV-1 and HSV-2 are closely related viruses. They behave similarly in the body, remain latent in the nervous system, and can reactivate over time. While the emotional weight placed on the word “herpes” often falls more heavily on genital cases, oral herpes can be painful, frequent, and socially distressing. Both types can also carry health implications beyond the blisters, including an increased risk of other infections and complications during childbirth.
Understanding that cold sores are a form of herpes helps to reduce the shame and misinformation that keeps people from getting tested, sharing their status, or seeking care. It’s not about labeling—it’s about being informed and compassionate, both with us and with others.
Myth #5: Herpes Isn’t That Common
A lot of people are surprised to learn just how widespread herpes really is. One of the most enduring herpes myths is the idea that it’s rare—that it only happens to “other people,” or only to those who are somehow at greater risk. But the numbers tell a very different story.
Herpes simplex virus infections are among the most common viral conditions worldwide. HSV-1, which primarily causes oral herpes, affects an estimated 3.75 billion people under the age of 50—that’s more than two-thirds of the global population in that age group. HSV-2, more closely associated with genital herpes, affects nearly half a billion people aged 15 to 49. These are not fringe numbers. They reflect an everyday reality for people across all walks of life.
Despite this, public understanding hasn’t caught up with the data. Many people don’t realize that cold sores are a form of herpes, or that herpes can be completely asymptomatic. As a result, the virus is often overlooked or underestimated, and people may assume they aren’t at risk. But most people with herpes don’t fit the stereotype. They often have no visible symptoms and no history of what’s considered “high-risk” behavior.
Looking more closely at global trends, HSV-1 is most commonly acquired during childhood, often through non-sexual contact. In some African countries, more than 90% of people have HSV-1 antibodies by their early twenties. HSV-2 is generally acquired later, and it’s more common among adults—especially women—and increases gradually with age and sexual experience. In Africa, where access to healthcare and sexual health education can be limited, the prevalence of HSV-2 reaches over 30%. In places like Southeast Asia and the Western Pacific, large populations contribute to high total numbers, even if the per-person rate is lower.
The sheer scale of these numbers helps normalize what many still see as taboo. HSV is more common than most other sexually transmitted infections, and yet it’s treated with a disproportionate amount of fear and silence. While most cases are mild and manageable, the virus can still have complications—especially during pregnancy or when it affects the eyes—which is why education matters.
The takeaway is simple: herpes is not rare, and it’s certainly not a reflection of someone’s choices or worth. It’s part of the human experience for billions of people. By recognizing how common it is, we can start to replace shame with knowledge—and that benefits everyone.
Myth #6: You Can’t Have a Healthy Sex Life with Herpes
Few herpes myths carry as much emotional weight as the idea that a diagnosis marks the end of a healthy, fulfilling sex life. The truth is far more hopeful: people with herpes can and do enjoy satisfying, connected, and safe sexual relationships. A diagnosis doesn’t take away your capacity for intimacy—it just adds a layer of awareness that can strengthen trust and communication.
Most people living with HSV find that, after an initial adjustment period, they resume sexual activity without lasting disruption. Learning how the virus behaves and understanding how to talk about it with partners often leads to more open, honest conversations—conversations that can deepen emotional intimacy and reduce anxiety. Disclosure, while sometimes difficult, has the power to foster trust rather than erode it.
From a medical standpoint, there are several effective ways to reduce the risk of transmission. Daily antiviral therapy, such as valaciclovir, can lower the likelihood of passing HSV-2 to a partner by nearly half and significantly reduce the chances of symptoms developing in someone newly exposed. Antivirals also decrease asymptomatic shedding, which is one of the primary ways herpes spreads without people realizing it.
Condoms, too, play an important role in protection. Consistent condom use has been linked to a much lower risk of HSV-2 infection—especially for women. Even using condoms in just a portion of sexual encounters has been shown to dramatically cut the risk of transmission. Behavioral strategies like avoiding sex during outbreaks, recognizing early warning signs (like tingling or itching), and getting tested together can make sex safer and more relaxed for both partners.
What often causes more distress than the virus itself is the stigma. Many people with herpes struggle with feelings of guilt, shame, or fear of rejection—emotional burdens that are made worse by a lack of public understanding. Historically, health campaigns have leaned heavily on fear, emphasizing risk over reality, and contributing to unnecessary isolation.
But stigma isn’t inevitable. When people have access to accurate, non-judgmental information, the narrative begins to shift. Herpes is manageable, common, and not a moral failing. With the right support and education, individuals can make informed choices, communicate clearly, and enjoy intimacy without fear.
Myth #7: A Positive Test Means Your Partner Cheated
Few herpes myths cause as much confusion and pain as the assumption that a new diagnosis must point to recent infidelity. It’s an understandable fear—herpes is often framed as something that appears quickly after exposure, with clear signs and a specific timeline. But the science tells a very different story.
Herpes simplex virus doesn’t follow a predictable script. Once someone is infected, the virus settles into the nervous system, where it can lie dormant for years. This is known as latency. HSV travels along the nerves to areas like the sacral or trigeminal ganglia and becomes inactive, often without causing symptoms. It’s not gone—it’s just being kept in check by the immune system. Reactivation can happen at any time, triggered by things like stress, illness, or hormonal shifts, and it doesn’t always produce visible sores. In fact, reactivation can be entirely symptomless.
This means someone could test positive for herpes long after they were actually exposed—sometimes even years later. Many people are diagnosed during a new relationship and understandably assume they must have just been infected. But it’s entirely possible, and even common, for the virus to have been present for a long time without detection. Antibody tests can confirm that a person has been exposed to HSV, but they can’t tell when the exposure happened or who passed it on. That uncertainty can create tension in relationships, especially when there’s already fear or stigma involved.
Unfortunately, stigma plays a big role in fueling suspicion. Herpes is often misunderstood and misrepresented, especially in media and pop culture. It’s portrayed as something that only happens to the reckless or unfaithful, which creates an environment of blame. In reality, HSV is extremely common, often symptomless, and not a reliable marker of someone’s behavior or honesty.
It’s natural to feel overwhelmed or confused after a diagnosis. But approaching the situation with compassion—and understanding how herpes actually works—can help preserve trust and connection. A positive test isn’t a verdict on someone’s relationship; it’s a chance to learn, support each other, and move forward with more clarity and care.
Why Busting These Myths Matters
The myths surrounding herpes don’t just misinform—they actively harm. While herpes itself is often mild and manageable, the stigma that clings to it can be deeply distressing. People with HSV frequently experience shame, anxiety, and fear of social rejection, not because of the virus itself, but because of how it’s misunderstood and portrayed.
This stigma discourages people from getting tested, seeking care, or talking to partners. Fear of being judged or seen as “unclean” leads many to avoid disclosure, even in committed relationships. That silence not only reinforces misinformation—it also increases the risk of transmission. When herpes is treated as a moral failure instead of a common medical condition, honest conversations become harder to have.
These cultural narratives are powerful. Ideas about sexual purity, personal responsibility, and character often get wrapped up in STI discussions, creating a cycle where people internalize guilt and shame for something that affects hundreds of millions globally. Breaking that cycle starts with challenging the stories we’ve been told.
Open, science-backed education is one of the most effective tools we have. When people have access to accurate, empathetic information, they’re more likely to make informed choices, feel confident in managing their health, and speak openly about their experiences. Whether it’s through a conversation with a healthcare provider, an educational video, or a supportive blog post, these efforts help shift herpes out of the shadows and into the realm of everyday health.
By replacing fear with facts and shame with support, we not only improve individual outcomes—we also move toward a more compassionate and informed culture. One where people living with herpes can care for themselves and others without fear of judgment.
Rewriting the Narrative Around Herpes
When it comes to herpes, the real harm often isn’t the virus itself—it’s the myths and misinformation that surround it. These false beliefs feed stigma, make it harder for people to seek care, and silence conversations that should be met with support and understanding.
The truth is, herpes doesn’t define anyone. It’s not a moral issue or a reason for shame. It’s a health condition—one that deserves the same empathy and clarity we’d extend to anything else affecting someone’s well-being. By replacing fear with facts and judgment with compassion, we can shift the conversation toward something healthier and more honest.
If this resonated with you, we’d love for you to join our mailing list. You’ll receive thoughtful, stigma-free content on sexual health, relationships, and wellness—because everyone deserves access to information that empowers rather than shames.
References
Bardell, D. (1993). Survival of herpes simplex virus type 1 in saliva and tap water contaminating some common objects. Microbios, 74(299), 81–87.
Bobrow, M. (2016). Full Disclosure: Herpes Stigma and Communication Practices among HSV+ Individuals.
Boyd, E. M. (2010). The Good Girl–Bad Girl Dichotomy: Sexual Double Standards, STDs, and Stigma Management. Symbolic Interaction.
Chung, H. (2014). Challenge of Developing a Herpes Simplex Virus Vaccine.
Corey, L., & Ashley, R. (2004). Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Herpes: The Journal of the IHMF, 11 Suppl 3, 170A–174A.
Deka, S., Jha, M. K., Gupta, P., Mahanta, P., & Kalita, D. (2025). A contemporary insight into the seroepidemiology of herpes simplex virus infection in the Sub-Himalayan region. The Scientific World Journal.
Ensor, D. (2005). The Significance of Herpes Simplex for School Nurses. The Journal of School Nursing, 21, 10–16.
Fatahzadeh, M., & Schwartz, R. (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737-763.
Fife, K. (2018). Herpes Therapy Enters the Molecular Age. Journal of Infectious Diseases, 218(11), 1689–1690.
Gray, S. (2018). Clinical Education Extra: Cold Sores. The Australian Pharmacist, 37, 62.
Holliday, A., Salih, A., & Wagner, R. (2014). Cold Sore, Cold Soul? An Examination of Orolabial Herpes in Film.
Hull, C., & Brunton, S. (2010). The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgraduate Medicine, 122(5), 1–6.
James, C. R., Harfouche, M., Welton, N., Turner, K., Abu-Raddad, L., Gottlieb, S., & Looker, K. (2020). Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 98, 315–329.
Johnston, C., Morrow, R., & Stanberry, L. (2014). Human Herpesviruses: Herpes Simplex Virus Types 1 and 2. In Human Herpesviruses (pp. 829-853).
Jungmann, E. (2004). Genital Herpes. Clinical Evidence, 11, 2073–2088.
Kasubi, M., Nilsen, A., Marsden, H., Bergström, T., Langeland, N., & Haarr, L. (2006). Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in Tanzania. Journal of Clinical Microbiology, 44, 2801–2807.
Koelle, D., & Wald, A. (2000). Herpes simplex virus: The importance of asymptomatic shedding. The Journal of Antimicrobial Chemotherapy, 45(Suppl T3), 1–8.
Kriesel, J., et al. (2011). C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. The Journal of Infectious Diseases, 204(11), 1654–1662.
Lachmann, R. (2003). Herpes simplex virus latency. Expert Reviews in Molecular Medicine, 5, 1–14.
Leone, P. (2004). Expert commentary: Genital herpes transmission. Herpes: The Journal of the IHMF, 11(2), 48–49.
Metcalfe, R., Caulfield, P., & Fargie, F. (2017). Using modern technology to improve the management of initial presentation of herpes simplex virus infection. Sexually Transmitted Infections, 93, A34.
Morand, P. (2002). [Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission]. Annales de Dermatologie et de Venereologie, 129(4 Pt 2), 577–585.
Nerurkar, L., West, F., May, M., Madden, D., & Sever, J. (1983). Survival of herpes simplex virus in water specimens collected from hot tubs in spa facilities and on plastic surfaces. JAMA, 250(22), 3081–3083.
Patel, R. (2004). Antiviral agents for the prevention of the sexual transmission of herpes simplex in discordant couples. Current Opinion in Infectious Diseases, 17(1), 45–48.
Patel, R. (2004). Educational interventions and the prevention of herpes simplex virus transmission. Herpes: The Journal of the IHMF, 11 Suppl 3, 155A–160A.
Pazin, G., & Harger, J. (1984). Transmission of herpes simplex. JAMA, 252(8), 1010–1011.
Rietmeijer, C., & Low, N. (2008). Herpes Complex. Sexually Transmitted Infections, 84, 330–331.
Roberts, R. E., & Marcos, S. (2016). Media Representations of Herpes.
Samandary, S., Kridane-Miledi, H., Sandoval, J. S., Choudhury, Z., Langa-Vives, F., Spencer, D., Chentoufi, A., Lemonnier, F., & BenMohamed, L. (2014). Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations. Human Immunology, 75(8), 715–729.
Schiffer, J. T., Mayer, B. T., Fong, Y., Swan, D. A., & Wald, A. (2014). Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. Journal of the Royal Society, Interface, 11(95), 20140160.
Schulte, J., Bellamy, A., Hook, E., Bernstein, D., Levin, M., Leone, P., et al. (2014). HSV-1 and HSV-2 seroprevalence in the United States among asymptomatic women unaware of any herpes simplex virus infection. Southern Medical Journal, 107, 79–84.
Shearer, L., Simmons, L., Mindel, A., Stanberry, L., & Rosenthal, S. (2011). Reducing the stigma of HSV through brief publicly-generated videos. Sexually Transmitted Infections, 87, A259.
Shearer, L., Simmons, L., Mindel, A., Stanberry, L., & Rosenthal, S. (2012). Reducing the stigma of herpes simplex virus infection: lessons from an online video contest. Sexual Health, 9(5), 438–444.
Straus, S., Rooney, J., & Hallahan, C. (1996). Acyclovir suppresses subclinical shedding of herpes simplex virus. Annals of Internal Medicine, 125, 776.
Suissa, C. A., Upadhyay, R., Dabney, M. D., Mack, R. J., Masica, D., & Margulies, B. (2022). Investigating the survival of herpes simplex virus on toothbrushes and surrogate phallic devices. International Journal of STD & AIDS, 34, 152–158.
Tronstein, E., Johnston, C., Huang, M.-L., Selke, S., Magaret, A., Warren, T., Corey, L., & Wald, A. (2011). Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA, 305(14), 1441–1449.
Tunbäck, P., Bergström, T., Andersson, A., Nordin, P., Krantz, I., & Löwhagen, G. (2003). Prevalence of herpes simplex virus antibodies in childhood and adolescence: A cross-sectional study. Scandinavian Journal of Infectious Diseases, 35, 498–502.
Turner, K. (2015). S03.2 Global and regional estimates of HSV2, HSV1 and neonatal herpes for 2012. Sexually Transmitted Infections, 91.
Ventura, A., Merajver, S., Shew, M., Kahn, J., DeKruyff, R., & Umetsu, D. (2013). HSV reactivation: HSV DNA in sensory ganglia neurons directs synthesis of proteins needed for HSV replication.
Wald, A., Langenberg, A., Krantz, E., Douglas, J., Handsfield, H., & Corey, L. (2005). The relationship between condom use and herpes simplex virus acquisition. Annals of Internal Medicine, 143(10), 707–713.
Wald, A., Langenberg, A., Link, K., Izu, A., Ashley, R., & Corey, L. (2001). Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA, 285(24), 3100–3106.
